Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter.
about
Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants versus Vitamin K Antagonist Oral Anticoagulants in Patients Undergoing Radiofrequency Catheter Ablation of Atrial Fibrillation: A Meta-AnalysisBleeding risks with novel oral anticoagulants during catheter ablation of atrial fibrillation: a systematic review and network meta-analysis.New oral anticoagulants compared to warfarin for perioperative anticoagulation in patients undergoing atrial fibrillation catheter ablation: a meta-analysis of continuous or interrupted new oral anticoagulants during ablation compared to interruptedEfficacy and Safety of Novel Oral Anticoagulants for Atrial Fibrillation Ablation: An Updated Meta-AnalysisThe clinical efficacy of dabigatran etexilate for preventing stroke in atrial fibrillation patientsThe role of novel anticoagulants in the management of venous thromboembolic disease.Practical issues in the management of novel oral anticoagulants-cardioversion and ablation.Periprocedural Management of New Oral Anticoagulants in Atrial Fibrillation Ablation.Use of Non-Vitamin K Antagonist Oral Anticoagulants in Special Patient Populations with Nonvalvular Atrial Fibrillation: A Review of the Literature and Application to Clinical Practice.Meta-Analysis of Efficacy and Safety of Apixaban in Patients Undergoing Catheter Ablation for Atrial Fibrillation.Atrial Fibrillation and Stroke - Increasing Stroke Risk With Intervention.Atrial Fibrillation and Stroke: Increasing Stroke Risk with InterventionAtrial Fibrillation and Stroke - Increasing Stroke Risk With Intervention.Are Some Anticoagulants More Equal Than Others? - Evaluating the Role of Novel Oral Anticoagulants in AF Ablation.New oral anticoagulants in patients undergoing atrial flutter radiofrequency catheter ablation: an observational study.Network meta-analysis of efficacy and safety of competitive oral anticoagulants in patients undergoing radiofrequency catheter ablation of atrial fibrillation.Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation.[Therapeutic management of non-valvular atrial fibrillation. Update 2013].Safety and efficacy of novel oral anticoagulants in the setting of atrial fibrillation ablation: Is it time to celebrate the "funeral" of warfarin?Uninterrupted Use of Oral Anticoagulants for the Ablation of Atrial Flutter: A Single Center Cohort of 154 Patients.Periprocedural dabigatran anticoagulation for atrial fibrillation ablation: do we have enough information to make a rational decision
P2860
Q35631782-43D5198F-FCA1-427F-A52A-4BBF4BA3D73EQ35765335-92BB1586-7FC5-4A42-A36B-3F93AE6D3008Q36247011-A435DCD8-2024-4F4A-923E-CF7B2F7A402DQ36999959-2A171E43-014B-4CD4-BF3F-69F116D94D6DQ37014482-F3AB41F0-85F0-4E4A-820E-BE84AC3FBED7Q38218874-97D2EA93-E3A7-40BD-8C8B-DEBDD8D1A03AQ38365022-F212CF1B-36F9-4547-8F0D-CD70E8192731Q38398014-F99FDEAE-F6CA-4F37-A7A6-1197CAE725EDQ38496232-7569C301-F6A1-423A-B102-A9F620D3AC61Q38614828-8CE596B5-5C48-4075-8381-FD7B358C788CQ38790283-FB4FC34F-D1BC-4626-B5F4-E248AA6D059FQ38804132-A1115FF7-58E5-47B4-881E-80F38F8E06D4Q38810698-E3A56449-6357-457E-B28A-A25852F8EDDFQ38826010-0CA1B079-651C-4AA6-8124-200D2AB1132DQ39078015-CE75BC9C-2E2F-4D75-BB33-C803E969E496Q39900127-1DEDAAB7-7ED2-4A6F-99B6-270CB3A99EFFQ43582249-D311F5E3-87BE-4C91-B877-05A4110F3E71Q44676772-CB1B5A9E-AD15-4AAA-B882-E3EFB46FD9C9Q48537715-6BA6688C-C8C5-4E3A-A476-B2548997C519Q55101663-F5AA16DD-11EE-4554-8D9C-C1B0C6D0C32EQ58479713-ADDC6802-6E9E-48BC-80E6-73BFC4DD2DE7
P2860
Continuous warfarin versus periprocedural dabigatran to reduce stroke and systemic embolism in patients undergoing catheter ablation for atrial fibrillation or left atrial flutter.
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Continuous warfarin versus per ...... lation or left atrial flutter.
@ast
Continuous warfarin versus per ...... lation or left atrial flutter.
@en
Continuous warfarin versus per ...... lation or left atrial flutter.
@nl
type
label
Continuous warfarin versus per ...... lation or left atrial flutter.
@ast
Continuous warfarin versus per ...... lation or left atrial flutter.
@en
Continuous warfarin versus per ...... lation or left atrial flutter.
@nl
prefLabel
Continuous warfarin versus per ...... lation or left atrial flutter.
@ast
Continuous warfarin versus per ...... lation or left atrial flutter.
@en
Continuous warfarin versus per ...... lation or left atrial flutter.
@nl
P2093
P2860
P1476
Continuous warfarin versus per ...... lation or left atrial flutter.
@en
P2093
Christopher R Ellis
Daniel W Kaiser
Megan M Streur
Rangadham Nagarakanti
S Patrick Whalen
P2860
P2888
P304
P356
10.1007/S10840-013-9793-7
P577
2013-04-28T00:00:00Z